2019
DOI: 10.1016/j.omto.2019.03.011
|View full text |Cite
|
Sign up to set email alerts
|

Sulforaphane Induces miR135b-5p and Its Target Gene, RASAL2, thereby Inhibiting the Progression of Pancreatic Cancer

Abstract: Pancreatic ductal adenocarcinoma (PDA) is one of the most lethal tumors, with poor therapeutic options in the advanced state. The broccoli-derived anti-inflammatory agent sulforaphane was shown to inhibit the progression of pancreatic cancer and other tumor entities. We examined the involvement of pancreatic cancer cell lines were evaluated by microRNA and gene expression arrays, bioinformatics, in silico analysis, qRT-PCR, western blotting, immunohistochemistry, in situ … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

2
16
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
5
1
1

Relationship

0
7

Authors

Journals

citations
Cited by 31 publications
(18 citation statements)
references
References 33 publications
2
16
0
Order By: Relevance
“…Questions remain regarding RASAL2 deregulation in tumour tissues. Interestingly, recent studies revealed that RASAL2 expression is controlled by specific miRNAs, including miR‐136, miR‐135b‐5p, and miR‐203 . Considering that RASAL2 is overexpressed in colorectal cancer, we aimed to determine whether it is regulated by specific miRNAs.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Questions remain regarding RASAL2 deregulation in tumour tissues. Interestingly, recent studies revealed that RASAL2 expression is controlled by specific miRNAs, including miR‐136, miR‐135b‐5p, and miR‐203 . Considering that RASAL2 is overexpressed in colorectal cancer, we aimed to determine whether it is regulated by specific miRNAs.…”
Section: Discussionmentioning
confidence: 99%
“…Interestingly, recent studies revealed that RASAL2 expression is controlled by specific miRNAs, including miR-136, miR-135b-5p, and miR-203. 17,40,41 Considering that RASAL2 is overexpressed in colorectal cancer, we aimed to determine whether it is regulated by specific miRNAs. Notably, we identified RASAL2 as a miR-876-5p target gene.…”
Section: Discussionmentioning
confidence: 99%
“…In terms of antitumor activity, sulforaphane has shown great potential for treatment of cancers such as bladder cancer (Xia, Kang, Jung, Zhang, & Lian, ), colon cancer (Darkwa, Burkhardt, & Tsuji, ), triple negative breast cancer (Jensen, Slattery, Housley, & Hansen, ), pancreatic cancer (Yin et al, ), prostate cancer (Traka et al, ), and non‐small cell lung cancer (Zheng et al, ). Although high numbers of studies have investigated the antitumor activity of sulforaphane, there is a need for a precise review to describe the mechanism of antitumor activity of sulforaphane.…”
Section: Significant Properties Of Sulforaphanementioning
confidence: 99%
“…In terms of antitumor activity, sulforaphane has shown great potential for treatment of cancers such as bladder cancer (Xia, Kang, Jung, Zhang, & Lian, 2019), colon cancer (Darkwa, Burkhardt, & Tsuji, 2019), triple negative breast cancer (Jensen, Slattery, Housley, & Hansen, 2019), pancreatic cancer (Yin et al, 2019), prostate cancer (Traka et al, 2019), and non-small cell lung cancer .…”
Section: Significant Properties Of Sulforaphanementioning
confidence: 99%
“…Moreover, growth-inhibitory effects for sulforaphane in head, neck and prostate cancer 583 cells have been reported (Singh et al 2005;Gupta et al 2015) and PEITC has been associated 584 with prevention of the growth of oral cancer cell lines (Chen et al 2012). Currently, their 585 potential effects on different cancer types is a matter of extensive exploration (Castro et al 586 2019;Mitsiogianni et al 2019;Upadhyaya, Liu & Dey 2019;Yin et al 2019). Sulphoraphane 587 has also been proposed as a potential therapy for precluding vascular complications in diabetes 588 (Yamagishi & Matsui 2016).…”
mentioning
confidence: 99%